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Background: The study investigated the effects and mechanism of duodenal-jejunal bypass (DJB) and sleeve
gastrectomy (SG) on the expression of liver GLUT2 and glucokinase (GCK) in diabetic rats.
Methods: Animal models of Goto–Kakizaki (GK) rats were established for the investigation of DJB and SG. Results of
weight, food intake, fasting plasma glucose level, oral glucose tolerance test and insulin were compared. Liver
tissues were harvested 8 weeks postoperatively. Reverse transcription-PCR and western blot were used to detect
liver GLUT2 and GCK mRNA and protein expression after operation.
Results: Fasting plasma glucose levels of DJB group and SG group in GK rats were markedly declined at 3 days and
l, 2, 4, 6, and 8 weeks postoperatively (P <0.01), whereas the levels of the sham-operated group only dropped at
3 days and 1 week postoperatively, and there were no significant differences 2 weeks postoperatively (P >0.05). In
the liver of GK rats, GLUT2 mRNA level and protein expression after DJB were higher than those in sham-operated
group and control group. GLUT2 mRNA level and protein expression after SG were significantly lower than those in
control group (P <0.01). GCK mRNA and protein experienced similar expression change.
Conclusions: Both DJB and SG can decrease the plasma glucose levels of GK rats, whereas they have different
effects on the expression of liver GLUT2 and GCK.
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According to WHO data, there were 175 million diabetic
patients in 2000, of which 90% were type 2 diabetes, and
the world incidence of diabetes showed a significant up-
ward trend year by year that is expected to double by
the year 2025 [1,2]. Complications in cardiovascular,
brain, kidney and other vital organs caused by diabetes
threaten patients’ health and life directly [3]. Although
drugs can control blood glucose level, they rarely make
patients’ blood glucose level become normal and do not
prevent diabetes complications. Strict diet and repeated
fluctuations in blood glucose levels place a continuous
mental stress on patients and affects their quality of life.* Correspondence: wstarding@hotmail.com
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reproduction in any medium, provided the orGastrointestinal reconstruction surgery is currently re-
ceiving much attention in type 2 diabetes treatment.
Investigators had found that many type 2 diabetes
patients achieved clinical resolution after bariatric sur-
gery of morbid obesity, which suggested that the dia-
betes may be cured by surgery. It was found that 95%
diabetes patients with normal body mass index have
controlled blood glucose after surgery [4]. Many studies
suggest that hormonal effect resulting from the anatom-
ical changes in the gastrointestine is the main mechan-
ism of long-term stability of controlling blood glucose.
However, there are studies that consider the high meta-
bolic status and low calorie intake to be the major fac-
tors in controlling plasma glucose [5].
At present, the mechanism research of surgical treat-
ment of diabetes mainly focuses on a variety of hormo-
nal changes produced by the surgery, including Grelin,
Obstatin, PYY, and GLP-1 [6,7], but studies on thel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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gery are rare. In the past, many studies increased the ex-
pression of glucose transport protein through genetically
modified methods and obviously improved blood glu-
cose levels. However, there are no reports on the expres-
sion level changes of glucose transporter protein
through gastrointestinal surgery.
In this experiment we use non-obese diabetic Goto–
Kakizaki (GK) rats as the experimental animal. There
are two methods: duodenal-jejunal bypass (DJB) reduces
absorption, and sleeve gastrectomy (SG) limits intake.
We aim to explore the effects of the two surgical meth-
ods on liver glucose transport protein 2 and liver gluco-
kinase (GCK) expression to understand the role of
surgery in glucose metabolism, and to study the mech-
anism of surgical treatment of diabetes.
Methods
Animals
The GK rat is a non-obese Wistar substrain which devel-
ops type 2 diabetes mellitus (DM) early in life. The
model was developed by Goto and Kakizaki at Tohoku
University, Japan in 1975. The GK rat is produced by se-
lective breeding (with glucose intolerance as a selection
index) repeated over many generations, starting from a
non-diabetic Wistar rat colony [8]. GK rats are widely
used in non-insulin-dependent DM (i.e. type 2 diabetes).
Male 8-week-old GK rats were purchased from Shanghai
Laboratory Animal Center (Shanghai, China). Rats were
housed individually in a controlled environment and main-
tained on a 12:12 artificial light/dark cycle with free access
to tap water and a 5.5% fat rat chow diet (Shanghai Labora-
tory Animal Center, Shanghai, China) throughout the ex-
periment. The energy density of the forage is 4.6 Kcal/Kg.
All studies were approved by the Shanghai Laboratory Ani-
mal Care Committee and carried out in compliance with
National Institute of Health standards.
Experimental design
Thirty two GK rats randomly underwent one of the fol-
lowing procedures(8 for each condition): duodenal je-
juna bypass group (DJB, n = 8), SG group (SG, n = 8),
sham-operated group (SHAM, n = 8) and control group
(CONT, n= 8). No significant differences were found
among the GK rats before surgery in terms of weight,
food-intake, fasting plasma glucose concentration and
mean plasma glucose.
After the rats had been acclimatized for 1 week, we
measured food intake daily and body weight twice
weekly. The preoperative baseline oral glucose tolerance
test (OGTT) was performed 1 week before the surgical
treatment and at Week 4 and Week 8 after the surgical
treatment. At 10 weeks old, the GK rats were randomly
assigned to one of the following procedures: DJB, SG,sham operation, and no operation, respectively. Fasting
plasma glucose levels were determined on tail vein blood
in conscious rats at 3 days and 1, 2, 4, 6, and 8 weeks
postsurgery. Plasma levels of insulin were measured at 2,
4, 6, and 8 weeks postoperatively. All the rats were sacri-
ficed to draw tissues for additional experimenting when
the rats were 32 weeks old.
Under light ether anesthesia, blood samples were
drawn from the retro-orbital venous plexus using hepar-
inized capillary tubes. After centrifugation, plasma sam-
ples were stored at −80 °C for later determination of
plasma insulin levels.
Liver tissues were separated into small pieces of 1 g weight
after having been fully washed with PBS. The tissues for
RNA detection were immersed into frozen pipe with RNA
stabilization solution RNALater (Qiagen, Valencia, CA,
USA), and tissues for protein detection were immersed into
frozen pipe with protease inhibitors. The frozen pipes were
immediately put into liquid nitrogen and stored at −80 °C.
Surgical procedures
After adaptive feeding of 2 weeks without any interven-
tion, all GK rats were randomly divided into four groups.
Rats undergoing any operation were made to fast but
were given free access to tap water overnight. At half an
hour before surgery, 50 mg/kg ceftriaxone was injected
into muscle and inhalation anesthesia with 0.5% pento-
barbital sodium in enterocoelia.
DJB surgery procedure: first, we degermed the skin,
made a 2.5 cm midline abdominal incision, identified the
structures, and separated the vessels from the pylorus.
Then, we transected the pylorus, and sutured continu-
ously with 5–0 silk to close the duodenum stump. We
transected the jejunum at a distance of 10 cm from the
ligament of treitz, and connected the distal jejunum to
the pylorus end-to-end anastomosis with 7–0 absorbable
silk, an end-to-side anastomosis with the proximal limb
and jejunum 15 cm distally was made with the same silk.
The gastric volume was preserved during the procedure.
SG surgery: first, the same incision as was done in the
DJB surgery was made, and gastric omentum was disso-
ciated to disclose gastric cardium. To dissect the fundus
and greater curve, ligation with 6–0 silk of the short ves-
sels towards the spleen and of the gastroepiploic vessels
in the region of the antrum was needed. Then, the vessels
of the greater curvature were cauterized with a thermo-
cautery, from the cardia all the way to the pylorus. This
arrangement defined the line of incision for the longitu-
dinal SG. This line covered the entire lumen and much
of the gastric fundus in which 70% of total stomach was
removed. After exeresis, the peritoneal cavity was cleaned
with saline before the gastrorrhaphy was conducted with
an invaginating continuous polypropylene (Prolene 6–0;























Figure 1 Mean± SD body weights of rats. Both SG and DJB groups show less weight gain compared with SHAM and CONT animals (P
<0.001). DJB group showed a more significant weight loss than SG group.
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Hemostasis and suture-line integrity were checked, and
an additional stitch was applied when necessary.
Sham surgeries involved the same incisions, transec-
tions and reanastomosis of the gastrointestine at mul-
tiple sites corresponding to those in SG and DJB. After
transection, the intestines were immediately anasto-
mosed. When needed, operative time was prolonged to
ensure a degree of anesthesiological stress that was
equivalent to that undergone by the SG and DJB rats.
CONT groups did not have an operation.
RNA extraction and real-time reverse transcription-PCR
Total RNA was extracted from cells using the Trizol re-
agent (Invitrogen, Carlsbad, CA, USA) following the
manufacturer’s directions. Reverse transcription was car-
ried out to convert mRNA into complementary DNA
following Invitrogen’s protocol. Quantitation of cDNAs


















Figure 2 Mean± SD food intake of rats. Both SG and DJB groups showwith the ABI Prism 7300 Sequence Detection System
(Applied Biosystems, Foster City, CA, USA).
Western blot analysis
For western blot detection of GLUT2 and GCK, liver tissues
were lysed in the lysis buffer consisting of 50 mmol/L
Trizma base (pH 8; Sigma, St. Louis, MO, USA), 1% Triton
X-100, 150 mmol/L NaCl, 20 Ag/mL leupeptin, 10 Ag/mL
aprotinin, 1 mmol/L phenylmethylsulfonyl fluoride, and
1 mmol/L sodium vanadate. Protein concentrations were
determined by the bicinchoninic acid protein assay (Pierce
Chemical Co., Rockford, IL, USA) using bovine serum albu-
min as standard. Equal protein aliquots were resolved by
SDS-PAGE, transferred to polyvinylidene fluoride mem-
branes, immunoblotted with primary antibody, and detected
with horseradish peroxidase-conjugated secondary antibody
(Bio-Rad Laboratories, Hercules, CA, USA) and enhanced
chemiluminescence reagent (Amersham Biosciences, Piscat-






























Figure 3 Mean± SD fasting glycemia. Mean fasting glycemia remained constantly lower in SG and DJB rats compared with SHAM and CONT
rats (P <0.001). There were no significant differences between SHAM rats and CONT rats (P >0.05).
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All statistical procedures were performed using SPSS
version13.0. Data were expressed as mean values ± SD.
Differences between groups were analyzed by two-wayFigure 4 a. OGTT was performed 4 weeks after operation. b. Another
improvement of glucose tolerance in both SG and DJB groups compared w
(P <0.001). SG group showed a better glucose tolerance than DJB group (Panalysis of covariance in combination with the unpaired
or paired Student's t-test when appropriate. When data
did not follow a normal distribution or failed the equal
variance test, the Mann–Whitney U test was used toOGTT was taken 8 weeks after operation. It showed an
ith the SHAM rats at 4 weeks as well as 8 weeks after operation
<0.001).
Figure 5 a. The variation tendency of insulin level at different times in GK rats. b. The variation tendency of insulin level of different
surgical treatment in GK rats. No statistical differences were observed among different times as well as different surgical treatments.
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sidered to be significantly different at P <0.05.
Results
Baseline (preoperative) evaluation
Before surgery, no significant differences were found
among the diabetic groups as well as the non-diabetic
groups in terms of weight, food intake, fasting plasma glu-
cose concentration, and mean plasma glucose during an
OGTT (data not shown).
Weight
The study showed that there were no statistical differ-
ences in body weight among groups before surgery(P
>0.05) (Figure 1). Both SG and DJB surgery lead to sig-
nificant weight loss compared with the SHAM rats and
CONT group rats (P <0.001) at the first 2 weeks after
surgery. The two groups started regaining body weight
approximately the 14th postoperative day. The mean
weights of CONT and SHAM groups did not differ fromone another at any period, and had a steady growing
trend.
Food intake
There were no significant differences among the groups
of GK rats on preoperative food intake (Figure 2). At the
first day postoperatively, food intake of DJB, SG and
SHAM groups had significant decreased (P <0.001),
whereas the CONT group remained stable. After that,
food intake of the three groups returned gradually. At
2 weeks postoperatively, food intake of SHAM group
approached that of the CONT group. No significant dif-
ferences were found between the two groups at Week 8
postoperatively (P >0.05). The food intake of DJB and
SG groups were significant lower than SHAM and
CONT groups.
Fasting plasma glucose level
Fasting plasma glucose levels of DJB group and SG
group in GK rats were markedly declined at 3 days
Figure 6 a. Mean± SD mRNA expression levels of liver GLUT2. b. Mean± SD protein expression levels of liver GLUT2. DJB operation
upregulated the expression of liver GLUT2 in GK rats, whereas SG downregulated the expression.
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whereas those of the SHAM group only dropped at
3 days and 1 week postoperatively, and there were
no significant differences 2 weeks postoperatively (P
>0.05) (Figure 3).
OGTT
This study showed that at Week 4 (Figure 4a) and Week
8 (Figure 4b) after surgery, OGTT were improved in
both SG and DJB rats compared with the SHAM and
CONT rats (P <0.001). The improvement of OGTT was
better in SG rats than in DJB rats.
Insulin level
Insulin was measured before and at 2, 4, 6 and 8 weeks
after operation. SG and DJB rats displayed inconspicuous
improvements in insulin levels after the operations com-
pared with SHAM and CONT rats, but no statistical dif-
ferences were observed (P >0.05) (Figure 5a, Figure 5b).
Expression level of liver GLUT2
The expression levels of liver GLUT2 mRNA in DJB
group were significantly upregulated compared withCONT group (P <0.05), however, the GLUT2 mRNA
expression levels of SG did not show statistical difference
compared with SHAM and CONT groups (P >0.05)
(Figure 6a). Expression of liver GLUT2 protein in DJB
was significantly higher than in CONT (P <0.001),
whereas SG was significantly lower than in CONT
(P <0.001), and there was no significant difference be-
tween SHAM and CONT (P <0.05) (Figure 6b).
Expression level of liver GCK
The mRNA and protein expression of liver GCK in DJB
was significantly higher than in CONT (P <0.01), and in
SG it was significantly lower than in CONT (P <0.001)
(Figure 7a, Figure 7b).
Discussion
In this present study, we performed gastrointestinal sur-
gery on GK rats to investigate the effects and mechan-
ism of DJB and SG on the expression of liver GLUT2
and GCK in diabetic rats. We found that both DJB and
SG can decrease the plasma glucose levels of GK rats,
whereas there are different effects on the expression of
liver GLUT2 and GCK. To our knowledge, this is the
Figure 7 a. Mean± SD mRNA expression levels of liver GCK. b. Mean± SD protein expression levels of liver GCK. DJB operation
upregulated the expression of liver GCK in GK rats, whereas SG downregulated the expression.
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transporter protein through gastrointestinal surgery.
Currently, there is an exponential increase in the
prevalence of type 2 diabetes within the population
worldwide. Current therapies including diet, exercise,
behavior modification, oral hypoglycemic agents, and in-
sulin [9-11] rarely return patients to euglycemia. For this
reason, an efficient way to treat patients with diabetes is
needed. There is evidence that bariatric surgery is an ef-
fective form of therapy for type 2 diabetes. It is reported
that SG and DJB for the treatment of type 2 diabetes in
obese patients are effective treatments for diabetes [12-
14], and they restore normal concentrations of plasma
glucose, insulin, and glycosylated hemoglobin in 80% to
100% of patients [15-17]. However, for normal weight or
slightly overweight patients with type 2 diabetes, the de-
bate on whether cutting most of the stomach is an ef-
fective way to treat diabetes continues.
Recent reports that glycemic control often occurs long
before significant weight loss [15,18] suggesting that the
control of diabetes may be a direct effect of theoperation rather than a secondary outcome of the ameli-
oration of obesity-related abnormalities. From this ex-
periment, the changes of diet and weight of SG and DJB
groups were consistent, they declined at first and then
rose slowly, but both the food intake and weight of SG
and DJB were significantly lower than that of the CONT
group. Furthermore, these effects were not seen in the
sham-operated animals despite similar operative time,
and the same postoperative food intake rates. This sug-
gests that SG and DJB could change the weight of a pa-
tient even in a non-obese animal model.
Similar effects with SG and DJB on OGTT, fasting
plasma glucose level, and plasma insulin level were
observed. Similar to previous observations, these surger-
ies achieved normal concentrations of fasting glycemia
and fasting plasma insulin [13,18-20], restored insulin
sensitivity [18,21-23], and prevented progression in
impaired glucose tolerance [21,22]. The results of SG
and DJB were significantly different from those of the
CONT group and the SHAM group. However, SG and
DJB rats displayed inconspicuous improvements in
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and CONT rats, but no statistical differences were
observed. These findings are consistent with previous
studies in humans in which the control of plasma glu-
cose and insulin has occurred before substantial weight
loss after bariatric surgery [24].
Previous studies [25,26] showed that glucose can in-
crease the level of GLUT2 mRNA. Glucose must pass
through the β-cell membrane to the cytoplasm before
the GCK can work, and the process is regulated by
GLUT2. This transmembrane transport is unlimited in
physiological circumstances, but glucose-stimulated in-
sulin secretion is impaired in the DM state, and the ex-
pression level of GLUT2 is significantly reduced. GCK
makes liver absorb glucose more easily during the high
level of glucose. Liver GCK deficiency can affect the
function of β-cell and impair insulin secretion. A de-
crease in the production of GCK or in the activity of
GCK can reduce glucose utilization, block glycogen syn-
thesis, and lead to elevated glucose levels [27]. The ex-
pression of GLUT2 and GCK are affected by many
factors. We used animal experiments, and a unified diet
and rearing environment, so that the level of glucose
metabolism of the liver can be investigated. The expres-
sion of liver glucose transporter protein and liver GCK
of the DJB group increased significantly compared with
the SHAM group. Though DJB did not alter stomach
capacity, gastrointestinal hormones were changed after
gastrointestinal anatomy which led to poor appetite, so
food intake in that group was low. The food intake in
SG was higher than in DJB at 8 weeks after surgery;
however, the expression of GCK and GLUT in SG was
lower than in DJB.
This study showed that DJB and SG on GK rats
improved blood glucose levels. The blood glucose level
of the SHAM group was improved in the short term,
but it returned to the preoperative level 2 weeks after
surgery. DJB and SG improved insulin levels slightly in
GK rats, but the differences were not statistically signifi-
cant. The mRNA and protein expression of liver GCK of
the DJB group were significantly increased, however, the
expression of GCK of the SG group was significantly
decreased. So we can conclude that the mechanism of
glucose metabolism in different surgical methods is
completely different.
Stomach capacity is still intact after DJB, however,
changes in the gastrointestinal anatomy lead to some
changes in gastrointestinal hormones: it amplifies the
function of insulin, promotes the expression of GCK
and enhances glycogen synthesis and thereby the blood
glucose is reduced [28]. After SG surgery, due to
restricted food intake, the amount of glucose entering
the blood was significantly reduced, which led to low
levels of glucose metabolism in the liver. Because thegastrointestinal structure was unaffected, the gastroin-
testine did not produce hormones that activate GCK,
and GCK expression was therefore lower than the
SHAM group and the CONT group. In this study, blood
glucose levels were not consistent with high expression
of GCK after DJB surgery in GK rats, which shows that
the hormone effect promoted over expression of GCK
after gastrointestinal bypass surgery.
Conclusions
The results suggest that different surgical methods can
produce completely different changes in glucose metab-
olism. For GK rats with a normal body mass index, just
limiting food intake does not improve the regulation of
blood glucose. Both DJB and SG can decrease the
plasma glucose levels of GK rats, whereas there are dif-
ferent effects on the expression of liver GLUT2 and
GCK. In summary, the study indicates that SG and DJB
are alternative methods of providing long-term control
of glycemia and normal levels of insulin with better clin-
ical advantages. In addition to providing good glycemic
control, the results of both operations presented herein
corroborate and extend previous work.
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